Raffa Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $360K | Buy |
1,432
+4
| +0.3% | +$861 | 0.05% | 71 |
|
|
2026
Q1 | $311K | Buy |
1,428
+47
| +3% | +$10.4K | 0.05% | 75 |
|
|
2025
Q4 | $315K | Buy |
1,381
+257
| +23% | +$58.5K | 0.05% | 75 |
|
|
2025
Q3 | $260K | Sell |
1,124
-218
| -16% | -$44.4K | 0.05% | 80 |
|
|
2025
Q2 | $249K | Buy |
1,342
+217
| +19% | +$40.3K | 0.05% | 82 |
|
|
2025
Q1 | $236K | Sell |
1,125
-43
| -4% | -$8.36K | 0.05% | 74 |
|
|
2024
Q4 | $207K | Buy |
1,168
+251
| +27% | +$46.1K | 0.05% | 76 |
|
|
2024
Q3 | $181K | Hold |
917
| – | – | 0.04% | 81 |
|
|
2024
Q2 | $157K | Hold |
917
| – | – | 0.04% | 100 |
|
|
2024
Q1 | $167K | Sell |
917
-10
| -1% | -$1.72K | 0.05% | 97 |
|
|
2023
Q4 | $144K | Sell |
927
-91
| -9% | -$13.3K | 0.04% | 83 |
|
|
2023
Q3 | $152K | Buy |
1,018
+6
| +0.6% | +$881 | 0.05% | 77 |
|
|
2023
Q2 | $136K | Buy |
1,012
+6
| +0.6% | +$880 | 0.05% | 78 |
|
|
2023
Q1 | $160K | Buy |
1,006
+617
| +159% | +$94.3K | 0.06% | 72 |
|
|
2022
Q4 | $62.9K | Buy |
389
+20
| +5% | +$3.07K | 0.03% | 119 |
|
|
2022
Q3 | $49.5K | Hold |
369
| – | – | 0.02% | 131 |
|
|
2022
Q2 | $56.5K | Hold |
369
| – | – | 0.03% | 127 |
|
|
2022
Q1 | $59.8K | Sell |
369
-45
| -11% | -$6.54K | 0.02% | 129 |
|
|
2021
Q4 | $56.1K | Sell |
414
-24
| -5% | -$2.83K | 0.02% | 145 |
|
|
2021
Q3 | $47.2K | Buy |
438
+27
| +7% | +$3.08K | 0.02% | 135 |
|
|
2021
Q2 | $46.3K | Buy |
411
+11
| +3% | +$1.24K | 0.02% | 144 |
|
|
2021
Q1 | $43.3K | Buy |
400
+32
| +9% | +$3.42K | 0.02% | 142 |
|
|
2020
Q4 | $39.4K | Buy |
368
+27
| +8% | +$2.6K | 0.01% | 143 |
|
|
2020
Q3 | $29.9K | Buy |
341
+101
| +42% | +$9.51K | 0.01% | 153 |
|
|
2020
Q2 | $23.6K | Buy |
240
+34
| +17% | +$2.99K | 0.01% | 161 |
|
|
2020
Q1 | $15.7K | Sell |
206
-193
| -48% | -$16.4K | 0.01% | 168 |
|
|
2019
Q4 | $35.3K | Hold |
399
| – | – | 0.01% | 156 |
|
|
2019
Q3 | $30.2K | Buy |
+399
| New | +$27.4K | 0.01% | 168 |
|
|
2019
Q2 | – | Sell |
-153
| Closed | -$12.3K | – | 734 |
|
|
2019
Q1 | $12.3K | Hold |
153
| – | – | 0.01% | 178 |
|
|
2018
Q4 | $14.1K | Hold |
153
| – | – | 0.01% | 189 |
|
|
2018
Q3 | $14.5K | Hold |
153
| – | – | 0.01% | 198 |
|
|
2018
Q2 | $14.2K | Hold |
153
| – | – | 0.01% | 189 |
|
|
2018
Q1 | $14.5K | Buy |
153
+116
| +314% | +$12.7K | 0.01% | 189 |
|
|
2017
Q4 | $3.58K | Hold |
37
| – | – | ﹤0.01% | 229 |
|
|
2017
Q3 | $3.29K | Buy |
+37
| New | +$2.82K | ﹤0.01% | 248 |
|
|
2017
Q1 | – | Sell |
-38
| Closed | -$2.38K | – | 376 |
|
|
2016
Q4 | $2.38K | Sell |
38
-100
| -72% | -$6.1K | ﹤0.01% | 266 |
|
|
2016
Q3 | $8.7K | Hold |
138
| – | – | ﹤0.01% | 186 |
|
|
2016
Q2 | $8.54K | Sell |
138
-1,243
| -90% | -$75.7K | ﹤0.01% | 181 |
|
|
2016
Q1 | $78.9K | Hold |
1,381
| – | – | 0.05% | 73 |
|
|
2015
Q4 | $81.8K | Hold |
1,381
| – | – | 0.05% | 66 |
|
|
2015
Q3 | $75.1K | Buy |
1,381
+100
| +8% | +$6.51K | 0.04% | 70 |
|
|
2015
Q2 | $86.1K | Buy |
1,281
+1,250
| +4,032% | +$81.6K | 0.05% | 67 |
|
|
2015
Q1 | $1.81K | Sell |
31
-5
| -14% | -$302 | ﹤0.01% | 282 |
|
|
2014
Q4 | $2.36K | Hold |
36
| – | – | ﹤0.01% | 238 |
|
|
2014
Q3 | $2.08K | Buy |
+36
| New | +$2K | ﹤0.01% | 251 |
|
|
2014
Q1 | – | Sell |
-36
| Closed | -$2.36K | – | 275 |
|
|
2013
Q4 | $2.36K | Buy |
+36
| New | +$1.77K | ﹤0.01% | 238 |
|
Other funds holding ABBV
Raffa Wealth Management's ABBV Position: Q2 2026 in Review
Raffa Wealth Management increased its AbbVie (ABBV) stake by 0.28% in Q2 2026, buying an estimated $861 and bringing the position to 1,432 shares worth $360K. The position accounts for 0.05% of the portfolio, ranked #71.
Raffa Wealth Management first reported a position in ABBV in Q4 2013 and has held it in 46 quarters since. 4,063 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Raffa Wealth Management held 1,432 shares of AbbVie worth $360K as of Q2 2026.
- Raffa Wealth Management bought 4 AbbVie shares in Q2 2026, an estimated $861.
- AbbVie made up 0.05% of Raffa Wealth Management's portfolio in Q2 2026, its #71 holding.
- Raffa Wealth Management first reported a position in AbbVie in Q4 2013 and has held it in 46 quarters since.
- 4,063 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Raffa Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.